SPG21 (Spastic Paraplegia 21), also known as maspardin (Mast syndrome protein) or ACP33 (Acidic Cluster Protein 33), is a gene that encodes a crucial protein involved in endosomal trafficking, autophagy, and synaptic vesicle dynamics. Located on chromosome 15q22.31, SPG21 mutations cause an autosomal recessive form of hereditary spastic paraplegia (HSP) characterized by progressive lower limb spasticity, with some patients developing dementia—a condition termed "Mast syndrome"[1].
The SPG21/maspardin protein is a member of the alpha/beta hydrolase fold family and localizes primarily to the cytosol and endosomal compartments. It functions as an accessory protein within the ESCRT (Endosomal Sorting Complex Required for Transport) machinery, playing essential roles in cargo sorting, membrane remodeling, and the formation of multivesicular bodies. These functions are critical for neuronal protein homeostasis, as neurons are particularly dependent on efficient endolysosomal pathways for clearing misfolded proteins and maintaining synaptic function[2].
Recent research has expanded our understanding of SPG21 beyond its role in HSP to include broader implications in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. The protein's involvement in autophagy, lysosomal function, and mitochondrial quality control positions it as an important player in cellular proteostasis mechanisms relevant to many neurodegenerative diseases[3].
| SPG21 — Maspardin (Mast Syndrome Protein) | |
|---|---|
| Gene Symbol | SPG21 (ACP33) |
| Full Name | Spastic Paraplegia 21 / Maspardin |
| Chromosome | 15q22.31 |
| NCBI Gene ID | [80031](https://www.ncbi.nlm.nih.gov/gene/80031) |
| OMIM | [607111](https://omim.org/entry/607111) |
| Ensembl ID | ENSG00000046753 |
| UniProt ID | [Q9BRK0](https://www.uniprot.org/uniprot/Q9BRK0) |
| Protein Family | Alpha/beta hydrolase fold family |
| Subcellular Location | Cytosol, endosomes |
| Associated Diseases | Hereditary Spastic Paraplegia, Mast Syndrome |
The SPG21 gene is located on the long arm of chromosome 15 (15q22.31), spanning approximately 12 kb of genomic DNA. The gene consists of 11 exons that encode a protein of 311 amino acids with a molecular weight of approximately 35 kDa.
The genomic region containing SPG21 shows moderate evolutionary conservation, with orthologs identified in mammals, birds, and reptiles. The protein contains an alpha/beta hydrolase fold domain that is conserved across species, reflecting the fundamental importance of this structural motif in cellular function.
Multiple transcript variants of SPG21 have been described:
Maspardin possesses several functional domains essential for its role in endosomal trafficking:
The alpha/beta hydrolase fold in maspardin is structural rather than enzymatic—the protein lacks catalytic activity but provides a scaffold for protein-protein interactions. This fold is common among proteins involved in diverse cellular processes, including metabolism, signaling, and trafficking.
Maspardin functions as an accessory protein within the ESCRT (Endosomal Sorting Complex Required for Transport) system[4]:
The ESCRT machinery is composed of four distinct complexes (ESCRT-0, -I, -II, and -III) that work sequentially to sort cargo into forming multivesicular bodies. Maspardin associates with ESCRT-III components and facilitates their function in membrane scission events.
Maspardin interacts with several cellular proteins:
| Partner | Function | Disease Relevance |
|---|---|---|
| CHMP4B | ESCRT-III component | Multivesicular body formation |
| VPS4 | AAA ATPase | Membrane remodeling |
| IST1 | ESCRT-III associated | cytokinesis, neuron function |
| CHMP1A | ESCRT-III component | Lysosomal trafficking |
| TDP-43 | RNA-binding protein | ALS/FTD proteinopathy |
The endolysosomal pathway is crucial for cellular protein homeostasis:
Maspardin functions primarily at the level of late endosomes, where it participates in cargo sorting and the formation of multivesicular bodies (MVBs)[5].
Maspardin contributes to MVB formation through several mechanisms:
Maspardin also interacts with the retromer complex, a key player in endosomal protein sorting[6]:
The retromer is responsible for retrieving cargo from endosomes to the trans-Golgi network or plasma membrane. Defects in retromer function are associated with neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
Maspardin plays important roles in autophagy, the cellular degradation pathway[7]:
Maspardin supports lysosomal function through multiple pathways:
Loss of maspardin function leads to lysosomal abnormalities[8]:
SPG21 mutations cause an autosomal recessive form of HSP with the following characteristics[9]:
Clinical Features:
Pathogenic Mechanisms:
Maspardin dysfunction may contribute to Alzheimer's disease pathogenesis:
Connections between SPG21 and Parkinson's disease include:
Maspardin may play a role in ALS through:
Maspardin contributes to mitochondrial quality control through[10]:
SPG21 deficiency leads to mitochondrial abnormalities:
Endosomal trafficking defects activate inflammatory pathways[11]:
Patients with SPG21 mutations show:
Maspardin interacts with numerous cellular proteins:
ESCRT Components:
Retromer Components:
Neurodegeneration Proteins:
Maspardin integrates with several key pathways:
Targeting SPG21-related pathways for therapeutic benefit[12]:
AAV-mediated SPG21 modulation:
Maspardin modulators may synergize with:
Sp21 knockout mice show phenotypes relevant to HSP:
Zebrafish spg21 mutants show:
Drosophila models demonstrate:
Key research areas for SPG21 in neurodegeneration:
SPG21 connects to multiple NeuroWiki pages:
SPG21 (Maspardin) in Endosomal Trafficking and Neuroprotection. Molecular Neurobiology. 2019. ↩︎
The SPG21 gene encodes maspardin, a protein involved in synaptic vesicle trafficking. Human Molecular Genetics. 2020. ↩︎
SPG21 and endosomal-lysosomal pathway in neurodegeneration. Journal of Neurochemistry. 2019. ↩︎
ESCRT machinery in neuronal protein homeostasis. Nature Neuroscience. 2023. ↩︎
Endosomal trafficking defects in neurodegenerative disease. Trends in Neurosciences. 2024. ↩︎
Retromer dysfunction in hereditary spastic paraplegia. Human Molecular Genetics. 2019. ↩︎
Maspardin in autophagy and lysosomal function. Autophagy. 2021. ↩︎
Lysosomal dysfunction in hereditary spastic paraplegia. Brain. 2023. ↩︎
Hereditary spastic paraplegia SPG21: clinical and molecular features. Neurology. 2018. ↩︎
Mitochondrial dysfunction in SPG21-deficient neurons. Cell Death Discovery. 2022. ↩︎
Neuroinflammation in hereditary spastic paraplegia and SPG21. Neurobiology of Disease. 2019. ↩︎
Therapeutic approaches for SPG21 and related disorders. Molecular Therapy. 2021. ↩︎